Abstract:The status quo of traditional Chinese medicine research and development(TCM R&D) both at home and abroad is analyzed from the eastern and western views,in order to present some rational suggestions for mastering the direction of TCM R&D in China.The historical review on references,expert consulting and field survey are adopted based on such background as TCM resources,industrial status,product structure,market economy and medical demand,especially focusing on Japan,German,USA and EU.The results are summarized as follows:1.Evolution in connotation and denotation of TCM;2.TCM R&D in China in three aspects:,TCM R&D focusing on tradition under the guidance of TCM theories;TCM R&D initiated by the notion of natural botanical drugs;TCM R&D in the direction of integrating TCM and natural botanical drugs;3.R&D trends of botanical drugs overseas and TCM in China,which show convergence in the reversal feature:neighboring countries benefit from TCM;perfect integration of excellent tradition and modern technologies in Europe;4.USA moves from the west to the east.Taken together,TCM R&D is in the category of high technology.We need to carry on and solve such key issues and links as "grade,quality,property,effect and use",integrate all the resources under the leadership of the government,focus on the characteristics of TCM,use the traditional experiences for reference,develop in innovation and move onward the modernization of TCM in China.

Comparative Study of Developmental Trends of Domestic and Foreign Chinese Medicine Research & Development